Use of amplification refractory mutation system PCR assay as a simple and effective tool to detect HIV-1 drug resistance mutations

Journal of Clinical Microbiology
Aubin J NanfackPhillipe N Nyambi

Abstract

Access to genotyping assays to determine successful antiretroviral treatment (ART) is limited in resource-constrained settings by high cost, suggesting the need for a cost-effective and simplified method to identify HIV-1 drug resistance (HIVDR) mutations. In this study, an amplification refractory mutation system (ARMS)-PCR assay was developed and used to investigate the most frequent HIVDR mutations affecting first-line ART in settings where WHO ART guidelines are applied. Seventy-five HIV-positive (HIV(+)) samples from Cameroon were used to assess the performance of this assay. Sequencing of HIV-1 reverse transcriptase was simultaneously performed for comparison, and discordant samples were tested with a Trugene HIV-1 genotyping kit. The ARMS-PCR assay was able to detect M184V, T215Y/F, K103N, and Y181C mutations with sensitivities of 96.8%, 85.7%, 91.3%, and 70%, respectively, and specificities of 90.6%, 95%, 100%, 96.9%, respectively, compared with data on sequencing. The results indicated the highest positive predictive value for K103N (100%) and the highest negative predictive value for M184V (97.5%). ARMS-PCR's limits of detection for mutations M184V, T215Y/F, K103N, and Y181C were <75 copies/ml, 143 copies/ml, 143 copi...Continue Reading

References

Jun 4, 1998·International Journal of Oncology·S Richter, A Seth
Jun 8, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·C AdjéUNKNOWN UNAIDS HIV Drug Access Initiative, Abidjan, Côte d'Ivoire
Jul 4, 2002·JAMA : the Journal of the American Medical Association·Robert M GrantJames O Kahn
Aug 9, 2002·The New England Journal of Medicine·Susan J LittleDouglas D Richman
Jul 21, 2004·Briefings in Bioinformatics·Sudhir KumarMasatoshi Nei
Jun 14, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin S HirschDouglas D Richman
Jun 6, 2009·Journal of Virological Methods·S SaravananKenneth H Mayer
Mar 11, 2010·Tropical Medicine & International Health : TM & IH·Charles KouanfackUNKNOWN Stratall ANRS 12110/ESTHER Study Group
Aug 20, 2010·AIDS Research and Human Retroviruses·Cyrille F DjokoMartine Peeters
May 11, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J DzangareR M Banda
Feb 5, 2013·Journal of the International AIDS Society·Avelin F AghokengMartine Peeters

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.